Oncolytic virus delivery: from nano-pharmacodynamics to enhanced oncolytic effect

With the advancement of a growing number of oncolytic viruses (OVs) to clinical development, drug delivery is becoming an important barrier to overcome for optimal therapeutic benefits. Host immunity, tumor microenvironment and abnormal vascularity contribute to inefficient vector delivery. A number...

Descripción completa

Detalles Bibliográficos
Autores principales: Yokoda, Raquel, Nagalo, Bolni M, Vernon, Brent, Oklu, Rahmi, Albadawi, Hassan, DeLeon, Thomas T, Zhou, Yumei, Egan, Jan B, Duda, Dan G, Borad, Mitesh J
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2017
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5687448/
https://www.ncbi.nlm.nih.gov/pubmed/29184854
http://dx.doi.org/10.2147/OV.S145262

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5687448/
https://www.ncbi.nlm.nih.gov/pubmed/29184854
http://dx.doi.org/10.2147/OV.S145262

Ejemplares similares